Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis - cytomed
Menu
Home
About
About Us
Our Team
Our Collaboration Partner
Manufacturer
Publications
Briefs
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Investor
Investor Relations
Financial Reports
Banking Services
Contact Us
Shareholder Benefits
Make An Appointment
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
«
Chimeric Switch Receptor: Switching for Improved Adoptive T-Cell Therapy Against Cancers
Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy
»
